Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease

Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease

Abstract Subjective cognitive decline (SCD) is regarded as the first clinical manifestation in the Alzheimer’s disease (AD) continuum. Investigating populations with SCD is important for understanding the early pathological mechanisms of AD and identifying SCD-related biomarkers, which are critical...

Full description

Bibliographic Details
Main Authors: Xiaoqi Wang, Weijie Huang, Li Su, Yue Xing, Frank Jessen, Yu Sun, Ni Shu, Ying Han
Format: Article
Language:English
Published: BMC 2020-09-01
Series:Molecular Neurodegeneration
Subjects:
subjective cognitive decline
Alzheimer’s disease
neuroimaging
multimodal MRI
PET
Online Access:http://link.springer.com/article/10.1186/s13024-020-00395-3

Similar Items

Similar Items